Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension

Abstract

In patients with SScPAH, increased ADMA serum levels and their negative association with exercise capacity suggests that the NO pathway is involved in the development of pulmonary vascular disease.